| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/22/2006 | CN1246458C Human cervical cancer 2 protooncogene and protein encoded therein |
| 03/22/2006 | CN1246333C Receptor in the EDb Fibronection domain |
| 03/22/2006 | CN1246326C Pineapple flavonoid glycoside compound and its use |
| 03/22/2006 | CN1246312C Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246300C Resorcinol derivatives |
| 03/22/2006 | CN1246278C Hyperforin derivatives, the use thereof and formulations containing them |
| 03/22/2006 | CN1245998C Suction stick fighting against senium and tonifying the kidney |
| 03/22/2006 | CN1245997C Suction stick for reducing fever, relieving sore-throat and anti diarrhea |
| 03/22/2006 | CN1245996C Stick of sucking incense for reducing fever and antivirus |
| 03/22/2006 | CN1245994C Use of salivary lactobacillus |
| 03/22/2006 | CN1245993C Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 03/22/2006 | CN1245989C Immune activator |
| 03/22/2006 | CN1245979C Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient |
| 03/22/2006 | CN1245978C Preventive or therapeutic drugs for various eosinophilia realated diseases containing chymase inhibitors as active ingredient |
| 03/22/2006 | CN1245974C Carvedilol |
| 03/22/2006 | CN1245967C Use of compound in making medicine |
| 03/22/2006 | CN1245963C Medicinal composition including bradycardiac substances and ist use |
| 03/21/2006 | US7015347 Stable no-delivering compounds |
| 03/21/2006 | US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders |
| 03/21/2006 | US7015315 first region having 2'-O-alkyl substituted nucleotide units where the alkyl has at least 2 carbon atoms, and a second region having 2'-deoxy sugar moieties, and which includes phosphorothioate linkages; nuclease resistance; hybridizes to single stranded DNA or RNA |
| 03/21/2006 | US7015252 comprises ubiquinones; decreasing amount of urinary 8-hydroxydeoxyquanosine in diabetic animals |
| 03/21/2006 | US7015241 Appetite-stimulating agents and remedies for anorexia |
| 03/21/2006 | US7015237 Pyridine matrix metalloproteinase inhibitors |
| 03/21/2006 | US7015235 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |
| 03/21/2006 | US7015232 Stablizer retards cyclization and discoloration of quinapril |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015218 Amide compounds and medicinal use thereof |
| 03/21/2006 | US7015213 Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 03/21/2006 | US7015210 Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 03/21/2006 | US7015202 Adjust migration of monocytes, lymphocytes or interleukins; controllinginfections |
| 03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 03/21/2006 | US7015195 Treatment of bone disorders with skeletal anabolic drugs |
| 03/21/2006 | US7015190 Administering peptides, mimetics or nucleic acids to interfere with cAMP binding proteins or with DNA so as to derepress cAMP-responsive gene expression; cognition activators; learning enhancement |
| 03/21/2006 | US7014866 High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same |
| 03/21/2006 | US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 03/21/2006 | US7014841 Delivery of antiemetics through an inhalation route |
| 03/21/2006 | US7014840 heating a thin coating to form a vapor then allowing to cool to form a condensation aerosol; kits |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | CA2399358C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |
| 03/21/2006 | CA2297292C Anhydrous compound for dyeing keratic fibres comprising the association of a water-soluble thickening polymer and of a nonionic amphiphilic polymer comprising at least one fatty chain |
| 03/21/2006 | CA2282254C Hydroxyazepanes as inhibitors of glycosidase and hiv protease |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2139112C Novel nicotinic acid esters |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/21/2006 | CA2062792C Treatment of androgen-related diseases |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2006028239A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | WO2006028226A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | WO2006028164A1 Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink |
| 03/16/2006 | WO2006028161A1 Serotonin 5-ht3 receptor agonist |
| 03/16/2006 | WO2006028160A1 S-oligonucleotide conjugate and antisense agent |
| 03/16/2006 | WO2006028110A1 Process for producing water-soluble hyaluronic acid modification |
| 03/16/2006 | WO2006028038A1 Sulfonamide derivative selectively inhibiting mmp-13 |
| 03/16/2006 | WO2006028007A1 Remedy for glomerular diseae |
| 03/16/2006 | WO2004110419A8 Agonist agents and medicinal compositions |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058508 Novel functional peptide nucleic acid and process for producing the same |
| 03/16/2006 | US20060058398 Medicinal compositions containing vitamin k's as nerve growth factor potentiator and utilization thereof |
| 03/16/2006 | US20060058395 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/16/2006 | US20060058394 Medicine of post-traumatic stress disorder |
| 03/16/2006 | US20060058392 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 03/16/2006 | US20060058389 Novel compounds that inhibit factor xa activity |
| 03/16/2006 | US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease |
| 03/16/2006 | US20060058368 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections |
| 03/16/2006 | US20060058366 Jnk inhibitor |
| 03/16/2006 | US20060058354 Conjugated aromatic compounds with a pyridine substituent |
| 03/16/2006 | US20060058350 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 03/16/2006 | US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 03/16/2006 | US20060058329 Pyrazole inhibitors of the transforming growth factor |
| 03/16/2006 | US20060058320 [1,2,4] Triazolo[1,5-c]pyrimidine derivatives |
| 03/16/2006 | US20060058310 Remedies for vertebral canal stenosis |
| 03/16/2006 | US20060058309 Respiratory syncytial virus replication inhibitors |
| 03/16/2006 | US20060058307 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 03/16/2006 | US20060058306 Solubilized topoisomerase poison agents |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058300 Intermediates of bupropion metabolites synthesis |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058291 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 03/16/2006 | US20060058289 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060058242 Dipeptide derivatives |
| 03/16/2006 | US20060057714 Vector |
| 03/16/2006 | US20060057218 N-[1-butyl-4-piperidinylmethyl[3,4-dihydro-2 oxazino[3,2-a indole-10 carboxamide as drugs with Cahpo4 or Ca3/po4/2 fillers or binders for use in treatment of irritable bowel syndrome, urinry incontience or arrhythmias |
| 03/16/2006 | US20060057146 Selective targeting of tumor vasculature using antibody molecules |
| 03/16/2006 | CA2579886A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | CA2579709A1 Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink |
| 03/16/2006 | CA2579204A1 Carbamoyl-substituted spiro derivative |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634951A1 Novel protein |
| 03/15/2006 | EP1634874A1 Imidazolidine derivative |
| 03/15/2006 | EP1634601A2 Dietary supplement comprising soyabean, mushroom and mung bean |
| 03/15/2006 | EP1634600A1 Antiallergic composition |
| 03/15/2006 | EP1634597A1 Compositions comprising dextromethorphan and quinidine or quinine for the treatment of emotional lability |